Latest Conference Articles

New findings show a unique series of markers could indicate particular black SLE patient risks.

Researchers have been unable to leverage new technology for ADHD screening.

Dr. David Goodman discusses the gaps in ADHD treatment.

A real-world study shows the therapy was slightly more efficacious for biologic-naive PsA patients.

A systematic review suggests patients taking immunosuppressive therapy may not be at as heightened risk of infection as previously thought.

An interview with a study author on the promising findings, and the use of ultrasonography in assessing psoriatic arthritis treatment.

Children hospitalized from the condition face a 14-fold increased risk of MACE.

The world is suddenly fixed on the field's most promising agents for an unprecedented virus. It's created a unique situation for specialists to collaborate.

The common rheumatic drug was found in a cohort analysis to be linked to greater regional TB outbreaks.

It is possible to diagnose patients with ADHD as young as 2 years old.

AXS-05 significantly relieved agitation, demonstrating a change from baseline in the CMAI total score of 15.4 compared to 11.5 for the placebo.

Less than 2% of surveyed families with rheumatic-disease children had reported a COVID-19 case in the early pandemic—and even fewer had physician-confirmed symptoms.

Treatment for ADHD is similar for adolescents and adult patients.

Dr. David Goodman will present 5 times during NEI about different ADHD issues and topics.

In the study, investigators tested the impact of the study drug in a rerandomized patient population that previously received a placebo.

A discussion on how the pandemic has burdened and, in some ways, bettered the very involved specialty.

A large portion of communication is non-verbal.

Clinicians rated 82% of the patients receiving the study drug and 46% in the placebo group as either much improved or very much improved on the Clinical Global Impression of Improvement scale.

Attempts to use neuroimaging to screen for ADHD in the past have failed.

Both methylphenidate PRC-063 and lisdexamfetamine led to improved performances for drivers with ADHD.

In new data presented at ACG 2020, investigators report on the clinical characteristics and outcomes of chronic pancreatitis patients with CDI.

Rifaximin and lactulose did not result in clinically relevant changes to fecal microbial antibiotic susceptibility profiles.

Up to 91% of the gastroenterologist respondents plan to integrate telehealth into their practice following the COVID-19 pandemic.

In data presented at ACG 2020, researchers show a combination of sulindac and eflornithine could be effective for FAP patients.

Data suggests a more scrutinized follow-up period following surgery.

A new ACG study shows that 18% would have been considered low risk for NASH-F based on FAST score despite having high liver stiffness measurement.

Researchers examine he prevalence of and factors influencing EPI treatment with PERT in pancreatic cancer.

Girish Hiremath, MD, MPH, discusses a need to more accurately and objectively assess pediatric compliance to eosinophilic esophagitis therapies.